500 patients67,039 observations150 daysLIVE
← Patients

Patient P-03412

Synthetic patientONX-7 · Day 107 · 25–34 · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
29%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 started — Baseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity-9
  • Inflammatory activity-6
  • GI instability+3
  • Treatment adherence-2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    5.3/10
    stable · -0.0 vs previous 14 d
    Stress level
    Daily log
    4.9/10
    worsening · +0.5 vs previous 14 d
    Pessimism score
    Daily log
    3.6/10
    stable · -0.1 vs previous 14 d
    Sleep quality
    Wearable
    25/100
    improving · +3.5 vs previous 14 d
    Libido
    Daily log
    4.2/10
    worsening · -0.5 vs previous 14 d
    HRV
    Wearable
    32.5 ms
    stable · -0.0 vs previous 14 d
    Toxicity
    Blood
    9/100
    worsening · +5.7 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 76 from the failing basin, 12 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +12.7
    • Butyrate producers intact
      hidden · steering +7.5
    • Daily walks resumed
      perturbation · steering +3.3
    • Protein
      supporter · GI -6.1 next day
    Main detractors to watch
    • Poor metabolizer
      hidden · steering -12.7
    • Caffeine
      perturbation · steering -11.1
    • Bacteroides fragilis elevated
      hidden · steering -7.4
    • Lactose
      perturbation · steering -7.4
    • Caffeine
      detractor · GI +6.8 next day
    • Lactose
      detractor · GI +4.4 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Caffeine
      +6.8detractor · 95%
    • Protein
      -6.1supporter · 95%
    • Lactose
      +4.4detractor · 95%
    • Dietary fat load
      -1.4no signal · 26%
    • Histamine load
      -0.6no signal · 15%
    • Alcohol
      +0.2no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling ↓60
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • WearableHRV 33 ms, trending down
    • Drug metabolism and exposure ↑40
      • DNACYP2D6 poor metabolizer → higher exposure
    • Mucosal barrier integrity ↓30
      • MicrobiomeAkkermansia low → thinner mucus layer
    • Butyrate / short-chain fatty acid production ↓25
      • MicrobiomeF. prausnitzii depleted
    • Autonomic recovery ↓20
      • WearableShort sleep window
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 3.9 · butyrate capacity 79/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiLow
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    34 ms
    Sleep
    6.4 h
    Steps
    9,822
    Resting HR
    57 bpm
    Daily log: GI score 27, nutritional resilience 61, adherence 91.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Protect a 7.5-hour sleep window; screens off 30 minutes before
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0318149%S03——75
    P-0325448%S06——66
    P-0335648%S14——66
    P-0305747%S14NP-02improved64
    P-0325847%S14NP-02no change59
    P-0342846%S16——62
    P-0343546%S08——64
    P-0348246%S05AD-05no change67
    P-0302045%S20——74
    P-0310745%S17——62
    P-0325245%S13SC-12improved68
    P-0346145%S03——62